NCT06781008 SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden
| NCT ID | NCT06781008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Jönköping County |
| Condition | Tick-Borne Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2023-09-01 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the SWEtick project is to increase the knowledge of the various clinical presentations of emerging tick-borne diseases (eTBD), to assess their importance for human health, to develop and validate laboratory methods for diagnosis of eTBD, and to develop recommendations for knowledge-driven management of patients with suspected eTBD within the Swedish healthcare system.
Eligibility Criteria
Inclusion Criteria in TBD and Non-TBD groups: * Clinical suspicion of tick-borne disease (physician's assessment based on medical history, symptoms, clinical findings and sometimes laboratory results) Exclusion Criteria: * Incapacitated to understand the study information and make decisions (adults and adolescents \>15 years)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06781008 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, studying Tick-Borne Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06781008 currently recruiting?
Yes, NCT06781008 is actively recruiting participants. Contact the research team at anna.jonsson.henningsson@rjl.se for enrollment information.
Where is the NCT06781008 trial being conducted?
This trial is being conducted at Falun, Sweden, Eksjö, Sweden, Jönköping, Sweden, Jönköping, Sweden and 8 additional locations.
Who is sponsoring the NCT06781008 clinical trial?
NCT06781008 is sponsored by Region Jönköping County. The trial plans to enroll 600 participants.